Categorized | Health

Acute Myeloid Leukaemia

Acute myeloid leukaemia, which is also known as acute myelogenous leukaemia, or AML, is a type of cancer that starts in the bone marrow. White blood cells, also called leukocytes, become malignant and start multiplying rapidly, destroying healthy blood cells and stopping them from functioning normally. AML is the most frequent form of acute leukaemia in adults. The risk to develop AML is thought to increase with age. If left undiscovered for a long time, AML starts progressing rapidly and results in the patient‘s death within a few weeks or months. The most common methods of treatment for AML are chemotherapy and stem cell transplantation.

The symptoms that patients of AML displayed are a result of cancerous blood cells replacing normal red and white blood cells and disrupting their work. The symptoms for AML include tiredness, weakness, shortness of breath, unusual bruising and increased risk of infection. Although several risk factors for AML have been identified, the specific cause of AML remains unclear.

Factors of increased risk to develop AML include certain non-cancerous blood conditions (myelodysplastic syndrome and myeloproliferative syndrome), genetic conditions (Down‘s syndrome), exposure to chemotherapy and radiation as well as carcinogenic chemicals, such as benzene.

Did you like this? Share it:

Comments are closed.